| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 | 12 | |
| BREAST | 957 | 20 | 1044 | 116 | 1412 | 199 | 1211 |
| ERLYTX | 95 | 1 | 52 | 8 | 97 | 11 | 67 |
| GI | 195 | 4 | 209 | 15 | 183 | 36 | 219 |
| GU | 453 | 9 | 470 | 39 | 475 | 71 | 432 |
| LEUK | 136 | 2 | 104 | 13 | 158 | 33 | 201 |
| LUNG | 250 | 5 | 261 | 15 | 183 | 27 | 164 |
| LYMPH | 384 | 7 | 365 | 32 | 390 | 68 | 414 |
| MELAN | 326 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 194 | 3 | 157 | 12 | 146 | 22 | 134 |
| MULT | 14 | 4 | 209 | 9 | 110 | 11 | 67 |
| OTHER | 37 | 1 | 52 | 1 | 12 | 7 | 43 |
| PREV | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3049 | 56 | 2923 | 260 | 3166 | 488 | 2970 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 | 6 | |
| CCD | 155 | 4 | 209 | 15 | 183 | 24 | 146 |
| ERLYTX | 11 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 679 | 17 | 887 | 57 | 694 | 111 | 676 |
| LUNG | 285 | 11 | 574 | 35 | 426 | 71 | 432 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| OTHER | 35 | 5 | 261 | 8 | 97 | 13 | 79 |
| PEOLC | 106 | 3 | 157 | 18 | 219 | 35 | 213 |
| PREV | 257 | 6 | 313 | 23 | 280 | 45 | 274 |
| SURV | 15 | 0 | 0 | 4 | 49 | 7 | 43 |
| SXQOL | 590 | 14 | 730 | 52 | 633 | 98 | 597 |
| Total | 2135 | 60 | 3131 | 213 | 2593 | 407 | 2478 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 0 | 3 | 18 | |
| BREAST | 957 | 20 | 1044 | 116 | 1412 | 199 | 1211 |
| CCD | 155 | 4 | 209 | 15 | 183 | 24 | 146 |
| ERLYTX | 106 | 1 | 52 | 9 | 110 | 12 | 73 |
| GI | 195 | 4 | 209 | 15 | 183 | 36 | 219 |
| GU | 453 | 9 | 470 | 39 | 475 | 71 | 432 |
| LEUK | 815 | 19 | 991 | 70 | 852 | 144 | 877 |
| LUNG | 535 | 16 | 835 | 50 | 609 | 98 | 597 |
| LYMPH | 385 | 7 | 365 | 32 | 390 | 69 | 420 |
| MELAN | 326 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 194 | 3 | 157 | 12 | 146 | 22 | 134 |
| MULT | 14 | 4 | 209 | 9 | 110 | 11 | 67 |
| OTHER | 72 | 6 | 313 | 9 | 110 | 20 | 122 |
| PEOLC | 106 | 3 | 157 | 18 | 219 | 35 | 213 |
| PREV | 261 | 6 | 313 | 23 | 280 | 45 | 274 |
| SURV | 15 | 0 | 0 | 4 | 49 | 7 | 43 |
| SXQOL | 592 | 14 | 730 | 52 | 633 | 98 | 597 |
| Total | 5184 | 116 | 6054 | 473 | 5761 | 895 | 5449 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 | 12 | |
| BREAST | 589 | 12 | 626 | 78 | 950 | 126 | 767 |
| ERLYTX | 51 | 0 | 0 | 4 | 49 | 7 | 43 |
| GI | 145 | 4 | 209 | 11 | 134 | 25 | 152 |
| GU | 386 | 5 | 261 | 28 | 341 | 56 | 341 |
| LEUK | 84 | 1 | 52 | 7 | 85 | 16 | 97 |
| LUNG | 157 | 4 | 209 | 9 | 110 | 15 | 91 |
| LYMPH | 243 | 2 | 104 | 15 | 183 | 39 | 237 |
| MELAN | 203 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 119 | 2 | 104 | 6 | 73 | 11 | 67 |
| MULT | 6 | 2 | 104 | 4 | 49 | 4 | 24 |
| OTHER | 37 | 1 | 52 | 1 | 12 | 7 | 43 |
| PREV | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2028 | 33 | 1721 | 163 | 1986 | 309 | 1880 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 | 6 | |
| CCD | 131 | 3 | 157 | 11 | 134 | 17 | 103 |
| ERLYTX | 11 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 309 | 7 | 365 | 22 | 268 | 46 | 280 |
| LUNG | 171 | 5 | 261 | 24 | 292 | 48 | 292 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| OTHER | 33 | 3 | 157 | 6 | 73 | 11 | 67 |
| PEOLC | 74 | 3 | 157 | 14 | 170 | 28 | 170 |
| PREV | 257 | 6 | 313 | 23 | 280 | 45 | 274 |
| SURV | 15 | 0 | 0 | 4 | 49 | 7 | 43 |
| SXQOL | 394 | 6 | 313 | 31 | 377 | 65 | 396 |
| Total | 1397 | 33 | 1723 | 136 | 1655 | 270 | 1643 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 0 | 3 | 18 | |
| BREAST | 773 | 16 | 835 | 94 | 1144 | 160 | 974 |
| CCD | 167 | 4 | 209 | 19 | 231 | 30 | 183 |
| ERLYTX | 62 | 0 | 0 | 5 | 61 | 8 | 49 |
| GI | 150 | 4 | 209 | 14 | 170 | 27 | 164 |
| GU | 402 | 5 | 261 | 30 | 365 | 57 | 347 |
| LEUK | 393 | 8 | 417 | 29 | 353 | 62 | 377 |
| LUNG | 329 | 9 | 470 | 33 | 402 | 63 | 384 |
| LYMPH | 244 | 2 | 104 | 15 | 183 | 40 | 244 |
| MELAN | 203 | 0 | 0 | 0 | 0 | 1 | 6 |
| MMYEL | 115 | 2 | 104 | 6 | 73 | 11 | 67 |
| MULT | 18 | 2 | 104 | 3 | 37 | 10 | 61 |
| OTHER | 243 | 9 | 470 | 27 | 329 | 49 | 298 |
| PEOLC | 83 | 4 | 209 | 15 | 183 | 29 | 177 |
| PREV | 261 | 6 | 313 | 23 | 280 | 45 | 274 |
| SURV | 15 | 0 | 0 | 4 | 49 | 7 | 43 |
| SXQOL | 396 | 6 | 313 | 31 | 377 | 65 | 396 |
| Total | 3857 | 77 | 4018 | 348 | 4237 | 667 | 4062 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 814 | 16 | 835 | 90 | 1096 | 161 | 980 |
| ERLYTX | 91 | 1 | 52 | 7 | 85 | 9 | 55 |
| GI | 106 | 2 | 104 | 10 | 122 | 22 | 134 |
| GU | 243 | 6 | 313 | 27 | 329 | 46 | 280 |
| LEUK | 104 | 2 | 104 | 11 | 134 | 29 | 177 |
| LUNG | 221 | 5 | 261 | 14 | 170 | 23 | 140 |
| LYMPH | 314 | 7 | 365 | 29 | 353 | 57 | 347 |
| MMYEL | 181 | 2 | 104 | 11 | 134 | 20 | 122 |
| MULT | 14 | 4 | 209 | 9 | 110 | 11 | 67 |
| Total | 2088 | 45 | 2347 | 208 | 2533 | 378 | 2302 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1969 | 39 | 2035 | 180 | 2192 | 345 | 2100 |
| AFFIL | 157 | 5 | 261 | 14 | 170 | 28 | 170 |
| CCOP/NCORP | 1299 | 22 | 1148 | 105 | 1278 | 206 | 1254 |
| Non-SWOG | 1755 | 47 | 2452 | 170 | 2070 | 312 | 1899 |
| Total | 5180 | 113 | 5896 | 469 | 5710 | 891 | 5423 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GI | S2001 | Rando II, Mets Pancreas , BRCA1/2, Comb Chemo | 1 | N | 23-OCT-25 |
| OTHER | NRGBN012 | Brain, Pre- vs Post-Op Stereotactic Radiosurg | 1 | E | 21-OCT-25 |
| LYMPH | S2207 | LBCL, Transplant Inelig, Targeted Tx + Tafa | 1 | T | 20-OCT-25 |
| LEUK | MM1OA-S03 | AML, Newly Dx, Ven+ASTX727 vs Ven+ASTX727+Ena | 1 | T | 08-OCT-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 17 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 11 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 11 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 7 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 6 |
| OTHER | 10323 | Moonshot Biobank Research | 1 | 5 |
| OTHER | NRGCC014 | High Risk, Bone Meta, Radiation Tx | 1 | 5 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 1 | 4 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 4 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 4 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 4 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 3 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |